mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.1 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.043 |
0.1 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |